Search clinical trials for: ADPM
Total 1264 results
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
PfizerMedivation, Inc.CompletedProstate CancerAustralia, United States, Spain, France, Korea, Republic of, Germany, Austria, United Kingdom, Belgium, Hungary, Italy, Brazil, Netherlands, Poland
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands
-
The Netherlands Cancer InstituteAstraZenecaCompleted
-
Jin LiNot yet recruitingRelapsed Ovarian Cancer
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingRecurrent Glioma | Low-grade Glioma | Glioma, Malignant | IDH2 Gene Mutation | IDH1 MutationUnited States
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
University of Turin, ItalyRecruiting
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
zr Pharma & GmbHCompletedPancreatic Cancer | Pancreatic Ductal AdenocarcinomaUnited States, Israel
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFallopian Tube Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Primary Peritoneal Cancer AJCC v7 | Stage IIIA Fallopian Tube Cancer AJCC v7 | Stage IIIA Ovarian Cancer AJCC v6 and v7 | Stage IIIA Primary Peritoneal Cancer AJCC v7 and other conditionsUnited States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
Latin American Cooperative Oncology GroupTerminated
-
Hoffmann-La RocheCompletedGynecologic NeoplasmsSpain, France, Australia, United Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
Tianjin Medical University Cancer Institute and...Recruiting
-
National Cancer Institute, NaplesRecruiting
-
Grupo Espanol Multidisciplinario del Cancer DigestivoMerk Sharp & Dohme España S.A.RecruitingMetastatic Colorectal CancerSpain
-
M.D. Anderson Cancer CenterRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
University Health Network, TorontoPfizerRecruiting
-
University Health Network, TorontoRecruitingGlioma | Solid Tumor | Cholangiocarcinoma | IDH MutationCanada
-
Gustave Roussy, Cancer Campus, Grand ParisSuspendedClear Cell Renal Cell Carcinoma | Head and Neck Cancer | Gastric Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Biliary Tract Cancer | Urothelial Bladder Cancer | Gastro-oesophageal Adenocarcinoma | Platinum-sensitive Urothelial Bladder CancerFrance
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterAstraZeneca; Janssen Scientific Affairs, LLCActive, not recruitingSarcoma | Sarcoma MetastaticUnited States
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLCCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Clovis Oncology, Inc.Active, not recruiting
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
-
Tesaro, Inc.Gynecologic Oncology GroupTerminated
-
Saitama Medical University International Medical...National Cancer Center, Japan; Tokyo University; Cancer Institute Hospital, Japan and other collaboratorsActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene MutationUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyWithdrawnBreast Cancer | Advanced Solid Tumor
-
Seoul National University HospitalAstraZenecaActive, not recruitingBreast NeoplasmsKorea, Republic of
-
AbbVie (prior sponsor, Abbott)CompletedBrain Diseases | Central Nervous System Diseases | Neoplasm Metastasis | Brain Neoplasms | Nervous System NeoplasmsUnited States, Canada, Puerto Rico
-
AbbVieCompletedBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Colon Cancer | Solid TumorsUnited States, Netherlands, Spain
-
Institut du Cancer de Montpellier - Val d'AurelleTerminated
-
New York State Psychiatric InstituteTemple University; The Zucker Hillside Hospital; Feinstein Institutes for Medical...Not yet recruitingSchizophrenia | Schizoaffective Disorder | Delusional Disorder | Schizophreniform Disorders | Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
-
University of UtahRepare TherapeuticsRecruitingChronic Lymphocytic LeukemiaUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
Gruppo Oncologico del Nord-OvestRecruitingPembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer (POINT)Nasopharyngeal CarcinomaItaly
-
Seoul National University HospitalActive, not recruitingBile Duct Cancer | Chemotherapy EffectKorea, Republic of
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
University Health Network, TorontoTesaro, Inc.Active, not recruiting